[unable to retrieve full-text content]
Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.
[unable to retrieve full-text content]
Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.
Brainfind is your one-stop shop for breaking news headlines and personalized news stories. Not only are we a news aggregator and content curator, we also allow registered users to publish their own articles on our website with full credit and their social links.